Resignation of executive director
Filed with HKEX · Stock code 3880 · · 1 page · English
The board (the "Board") of directors (the "Director(s)") of Medtide Inc. (the "Company") hereby announces that Ms. Li Lingmei（李玲梅）("Ms. Li") resigned as an executive Director with effect from September 24, 2026 due to personal work arrangements. Ms. Li has confirmed to the Company that she has no disagreement with the Board and there were no matters in relation to her resignation that need to be b
Earlier from Medtide
- Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
- 2026 Interim report
- CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway
- Articles of association
Later from Medtide
- List of directors and their roles and functions
- Voluntary announcement update on the strategic expansion of large-scale peptide CDMO production capacity
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Medtide into a list and get an email when it puts out news.
Follow Medtide